When was Eccogene founded?

Eccogene was founded in 2018 and raised its 1st funding round 2 years after it was founded.

Where is Eccogene located?

Eccogene is headquartered in Pudong, China.

Who is the current CEO of Eccogene?

Jingye Zhou of Eccogene. They have also founded 1 company.

How many employees does Eccogene have?

As of Aug 31, 2026, the latest employee count at Eccogene is 31.

Is Eccogene a funded company?

Eccogene is a funded company, having raised a total of $40.5M across 3 funding rounds to date. The company's 1st funding round was a $***** Series B round, raised on Dec 22, 2020.

When was the latest funding round of Eccogene?

Eccogene's latest funding was a $***** Series B round on Jun 12, 2023, with participation from 5 investors.

Where does Eccogene rank among its competitors?

Eccogene ranks 1st amongst 8 active competitors, of which 3 are funded. It stands 1st in terms of total funding among its competitors. The most recent competitor to raise funding was Eccogene, which secured $25.2M in Jun, 2023.

Who are the top competitors of Eccogene?

Eccogene's top competitors include Prosciento, Profil and AtG. Among them, Eccogene secured the most recent funding round in June, 2023.

Eccogene - 2026 Company Profile, Team, Funding & Competitors

Company Details

Website: www.eccogene.com
Email ID: *****@eccogene.com

Key Metrics

Founded Year

2018

Location

Pudong, China

Stage

Series B

Total Funding

$40.5M in 3 rounds

Latest Funding Round

Series B, Jun 12, 2023, $*****

Investors

New Alliance Capital & 9 more

Ranked

1^st among 8 active competitors

Employee Count

31 as on Aug 31, 2026

Similar Companies

Prosciento & 8 more

View Eccogene's full profile

Eccogene has raised a total funding of $40.5M over 3 rounds. Its first funding round was on Dec 22, 2020. Its latest funding round was a Series B round on Jun 12, 2023 for $*****. 5 investors participated in its latest round. Eccogene has 10 institutional investors.

Here is the list of recent funding rounds of Eccogene:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Jun 12, 2023	9650761	Series B	9700335	5423521	8481996	9579513
Mar 16, 2021	9498406	Series B	6067381	2563005	2025430	Chengyi Pharmaceutical & 3 more
Dec 22, 2020	9902187	Series B	9195737	6384646	7419834	Huagai Capital & 2 more

Access funding benchmarks and valuations. Sign up today!

View details of Eccogene's funding rounds and investors

The founders of Eccogene is Jingye Zhou. Jingye Zhou is the CEO of Eccogene.

Here are the details of Eccogene's key team members:

Jingye Zhou: Co-Founder & CEO of Eccogene.
Contact Info: 1 email address

View details of Eccogene's Founder profiles and Board Members

Eccogene's employee count trend

Eccogene has 31 employees as of Aug 26. Here is Eccogene's employee count trend over the years:

Uncover Eccogene's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Eccogene include Prosciento, Profil and AtG. Here is the list of Top 10 competitors of Eccogene, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Eccogene 2018, Pudong (China), Series B	CRO focused on development of drugs for metabolic and immune-related diseases	$40.5M	Delos Capital, Delos Capital Partners & 8 others	50/100
2nd	Prosciento 2003, Chula Vista (United States), Series B	CRO focused exclusively on diabetes, obesity and NAFLD/NASH	-	1315 Capital, Shenzhen Hepalink Pharmaceutical	41/100
3rd	Profil 1999, Neuss (Germany), Funding Raised	Provider of clinical research services for diabetes and obesity studies	-	Land, Europa	37/100
4th	AtG 2021, Barcelona (Spain), Seed	CRO focused on providing drug discovery and development services to metabolic disease	$568K	Blue Goose Capital, WA4STEAM & 2 others	32/100
5th	Hepart Group Kreuzlingen (Switzerland), Unfunded	Provider of pharmaceuticals for metabolic diseases	-	-	20/100
6th	HV Clinical Trials 2024, Wappingers Falls (United States), Unfunded	Provider of clinical trial services specializing in obesity and diabetes	-	-	16/100
7th	Parnassus Medical Systems 2012, Houston (United States), Unfunded	Provider of drug discovery services to metabolic disease	-	-	16/100
8th	Pancreas Divisum 2020, Charleston (United States), Unfunded	Provider of clinical trial services for pancreatitis	-	-	16/100
9th	Nephro Trials 2020, Miami (United States), Deadpooled	Provider of clinical trial services to metabolic and nephrology	-	-	15/100
10th	Coastal Metabolic Research Centre 2015, Ventura (United States), Deadpooled	Provider of clinical trial services to metabolic disease	-	-	15/100